High‐ and low‐dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes: A randomized control trial

Documenti analoghi

• Moderation of treatment outcomes by polygenic risk for alcohol‐related traits in placebo‐controlled trials of topiramate
  di: Henry R. Kranzler, et al.
  Pubblicazione: (2025)
• Acute changes in immune biomarkers under low‐ and moderate‐dose alcohol in light and heavy drinkers: A randomized, placebo‐controlled trial
  di: Mollie A. Monnig, et al.
  Pubblicazione: (2025)
• Multi‐ancestry genome‐wide association study of topiramate's effects on heavy alcohol use
  di: Christal N. Davis, et al.
  Pubblicazione: (2025)
• Effect of N‐acetylcysteine on neural alcohol cue reactivity and craving in adolescents who drink heavily: A preliminary randomized clinical trial
  di: ReJoyce Green, et al.
  Pubblicazione: (2024)
• Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults
  di: Sharon Lipperman‐Kreda, et al.
  Pubblicazione: (2024)